A detailed history of Caitlin John, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Caitlin John, LLC holds 342 shares of ABT stock, worth $43,728. This represents 0.03% of its overall portfolio holdings.

Number of Shares
342
Previous 403 15.14%
Holding current value
$43,728
Previous $46.7 Million 17.05%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$111.93 - $119.39 $6,827 - $7,282
-61 Reduced 15.14%
342 $38.7 Million
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $1.18 Million - $1.39 Million
-11,755 Reduced 96.69%
403 $46.7 Million
Q2 2024

Jan 27, 2025

BUY
$100.73 - $112.44 $1.54 Million - $1.71 Million
15,249 Added 4458.77%
15,591 $1.62 Billion
Q1 2024

Jan 27, 2025

BUY
$109.52 - $120.96 $1.44 Million - $1.59 Million
13,152 Added 3845.61%
13,494 $1.53 Billion
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $1.1 Million - $1.34 Million
12,158 New
12,158 $1.34 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Caitlin John, LLC Portfolio

Follow Caitlin John, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitlin John, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caitlin John, LLC with notifications on news.